Dr. Reddy’s to acquire US prescription portfolio from Mayne Pharma for $105 million
The portfolio includes 40 approved off-market products, including approximately 45 commercial products, 4 products in development, and many generic products focused on women’s health. Dr. Reddy’s Laboratories Ltd said on
